Covington & Burling LLP operates as a limited liability partnership worldwide, with the practice in England and Wales conducted by an affiliated
limited liability multinational partnership, Covington & Burling LLP, which is formed under the laws of the State of Delaware in the United States
and authorized and regulated by the Solicitors Regulation Authority with registration number 77071..
Jeremy Hutcher advises on complex technology transactions across industries, with a practice increasingly defined by the AI-driven digital transformations reshaping how clients operate. He structures and negotiates the commercial arrangements – collaborations, licensing, development and commercialization, services and outsourcing arrangements, as well as other strategic alliances – through which technology and data are deployed to build new businesses and transform existing ones. His clients regularly engage him on transactions at the frontier of their industries – novel commercial arrangements in emerging and rapidly evolving areas of growth.
In healthcare and life sciences, Jeremy is a member of Covington’s Digital Health Initiative and one of the firm’s leading advisors on the development and commercialization of health technology, products, and services. His work spans MedTech and HealthTech services agreements and collaborations, AI-enabled drug discovery and development arrangements, Software as a Medical Device (SaMD) transactions, and diagnostics development and commercialization matters. He advises clients across the full range of AI transactions in healthcare and life sciences, including those where AI is the product being commercialized or a tool deployed to discover new drugs, deliver services or improve clinical and operational outcomes. He also advises health systems on the technology and services transformations driving modern healthcare delivery and counsels clients on health data licensing matters.
Beyond healthcare and life sciences, Jeremy advises clients across industries, including in travel, sports, and media, on their most complex technology transactions, with particular experience in technology platform development, commercialization and distribution arrangements.
Jeremy’s outsourcing practice spans the full spectrum of strategic sourcing transactions across industries. His experience includes information technology outsourcing (ITO), business process outsourcing (BPO), revenue cycle services, as well as the transformation of traditional services engagements into AI-driven service delivery models, including agentic AI arrangements.
Advised Takeda on its multi-year expansion of a strategic collaboration with Beacon Biosignals to accelerate data-driven development of sleep biomarkers and patterns, and to support new diagnostic pathways addressing longstanding care gaps in narcolepsy.
Advising Sanofi in a multi-target strategic research collaboration with Insilico Medicine involving the use of an AI-driven platform to identify, synthesize and advance high-quality lead therapeutic compounds to development candidate stage, with a total deal value of up to $1.2 billion.
Advising AstraZeneca on the sale of its AMAZE disease management platform and a new digital health collaboration with Huma Therapeutics.
Advising Sanofi in a drug discovery collaboration with Exscientia to use Exscientia’s AI-driven platform to develop novel small molecule candidates for targets in oncology and immunology, with a total deal value of up to $5.2 billion.
Advising Sanofi in connection with its collaboration with, and investment into, Owkin, Inc., regarding a discovery and development partnership making use of a digital, federated learning clinical research platform.
Advising AstraZeneca on its global digital health partnership with BrightInsight for the development of digital health products and services (including Software as a Medical Device products).
Advising AstraZeneca regarding the development, clinical evaluation and commercial launch of the AMAZE Health Management platform.
Advising AstraZeneca regarding a collaboration and services arrangement with a technology company to develop and support a combination product comprised of a drug and a digital health tool.
Advising Astellas Pharma Inc. regarding its collaboration and license agreement with Welldoc to develop and commercialize digital health solutions for patients with diabetes and in other therapeutic areas.
Advising a global pharmaceutical company regarding its clinical research arrangements involving the study of digital health products for the treatment of ALS.
Advising Ascension and AMITA Health regarding its arrangements with R1 RCM for the provision of revenue cycle services across its acute care-based facilities and physician groups.
Advising Monumental Sports & Entertainment in connection with its partnership with William Hill to create the first sportsbook at a U.S. professional sports venue.
Advising the WWE in its deals with Endeavor Streaming and Massive Interactive to redesign and relaunch WWE Network.
Advising the National Hockey League on its partnership with GameOn regarding the launch and operation of the AI-powered NHL Chatbot.
Advising the LA Clippers on its partnership with Second Spectrum regarding the development and operation of an AI-enhanced, augmented reality video streaming product.
Advising Riot Games on its long-term commercialization partnership with BAMTech.
Advising the National Basketball Association on its virtual reality agreement with NextVR.
Advising the National Basketball Association on its global merchandising and marketing partnership with Nike.
Advising Turner Sports on the extension of its “March Madness” rights with the NCAA.
Advising American Airlines on the licensing of the “TWA” brand in connection with the TWA Hotel located at JFK Airport.
Advising the National Football League on its next generation data collaboration with Sportradar, a European sports data company.
Advising the National Hockey League on its digital rights partnership with Major League Baseball Advanced Media.
Advising sports teams in connection with the negotiation of their local media rights agreements.
Advising the National Geographic Society in connection with its entry into a joint venture with 21st Century Fox covering cable television, technology and media assets.
Advising Piramal Enterprises in the acquisition of anesthesia and pain management injectable products from Janssen.
Advising Apple Leisure Group in a series of information technology transactions.
Back
